CINBIO, Universidad de Vigo, 36310 Vigo, Spain.
Grupo de Investigación en Enfermedades Raras y Medicina Pediátrica, Instituto de Investigación Sanitaria Galicia Sur (IIS Galicia Sur), SERGAS-UVIGO, Vigo, Spain.
J Med Genet. 2023 Dec 21;61(1):18-26. doi: 10.1136/jmg-2023-109175.
Alström syndrome (ALMS; #203800) is an ultrarare monogenic recessive disease. This syndrome is associated with variants in the gene, which encodes a centrosome-associated protein involved in the regulation of several ciliary and extraciliary processes, such as centrosome cohesion, apoptosis, cell cycle control and receptor trafficking. The type of variant associated with ALMS is mostly complete loss-of-function variants (97%) and they are mainly located in exons 8, 10 and 16 of the gene. Other studies in the literature have tried to establish a genotype-phenotype correlation in this syndrome with limited success. The difficulty in recruiting a large cohort in rare diseases is the main barrier to conducting this type of study.
In this study we collected all cases of ALMS published to date. We created a database of patients who had a genetic diagnosis and an individualised clinical history. Lastly, we attempted to establish a genotype-phenotype correlation using the truncation site of the patient's longest allele as a grouping criteria.
We collected a total of 357 patients, of whom 227 had complete clinical information, complete genetic diagnosis and meta-information on sex and age. We have seen that there are five variants with high frequency, with p.(Arg2722Ter) being the most common variant, with 28 alleles. No gender differences in disease progression were detected. Finally, truncating variants in exon 10 seem to be correlated with a higher prevalence of liver disorders in patients with ALMS.
Pathogenic variants in exon 10 of the gene were associated with a higher prevalence of liver disease. However, the location of the variant in the gene does not have a major impact on the phenotype developed by the patient.
Alström 综合征(ALMS;#203800)是一种极其罕见的单基因隐性遗传病。该综合征与 基因中的变异有关,该基因编码一种与中心体相关的蛋白,参与调节几种纤毛和细胞外过程,如中心体黏合、细胞凋亡、细胞周期控制和受体运输。与 ALMS 相关的变异类型主要是完全丧失功能的变异(97%),它们主要位于基因的外显子 8、10 和 16 中。文献中的其他研究试图在该综合征中建立基因型-表型相关性,但收效甚微。在罕见病中招募大样本量是进行此类研究的主要障碍。
在本研究中,我们收集了迄今为止发表的所有 ALMS 病例。我们创建了一个包含具有遗传诊断和个体化临床病史的患者的数据库。最后,我们试图使用患者最长等位基因的截断位点作为分组标准来建立基因型-表型相关性。
我们共收集了 357 例患者,其中 227 例具有完整的临床信息、完整的基因诊断和性别及年龄的元信息。我们发现有五个高频变异体,其中 p.(Arg2722Ter)是最常见的变异体,有 28 个等位基因。未发现疾病进展存在性别差异。最后,外显子 10 中的截断变异似乎与 ALMS 患者肝脏疾病的更高患病率相关。
基因外显子 10 中的致病性变异与肝脏疾病的更高患病率相关。然而,基因中变异的位置对患者表现型的发展没有重大影响。